NL-OMON26332已完成不适用
Adherence and patient'experiences with the use of erlotinib in NSCLC treatment: the influence on plasma concentration and the exploration of factors affecting the use in daily practice.
VU medical centre, Amsterdam0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •NSCLC patients starting with erlotinib.
排除标准
- •Younger than 18 year or insufficient knowledge of the Dutch language.
研究者
相似试验
已完成
不适用
Adherence and patients’ experiences with capecitabine.Colorectal cancer, gastric cancer and breast cancer.NL-OMON21382VU University Medical Center66
已完成
不适用
Adherence and patients’ experiences with oral anticancer agents.cancerNL-OMON21194VU University Medical Center200
进行中（未招募）
4 期
A clinical trial of patient adherence and treatment outcome in supervised versus non-supervised artesunate/sulphadoxine - pyrimethamine treatment in uncomplicated falciparum malariaCTRI/2014/10/005105Dr Chiranjib Bagchi Calcutta School of Tropical Medicine62
尚未招募
不适用
A study on treatment awareness, adherence(compliance) and variation in prescription pattern in COPD patientsCTRI/2019/06/019919Seth GS Medical College and KEM Hospital
已完成
不适用
Adherence and patients' experiences with the use of erlotinib in NSCLC treatment: The influence on plasma concentration and the exploration of factors affecting the use in daily practicenon-small-cell-lung cancer or lung cancer10038666NL-OMON33122Vrije Universiteit Medisch Centrum50